
The Washington Post @washingtonpost
Novavax issued a “going concern” warning to investors Tuesday. The company’s negative disclosure caused the stock price to plunge even further from its speculative peak of $290 a share two years ago. On Wednesday, the stock traded below $7. https://t.co/Efddb0XkhI — PolitiTweet.org